NPPA Fixes Ceiling Price of Several Formulations under Drugs (Prices Control) Order, 2013
The manufacturer shall issue a price list in Form–V from date of Notification to NPPA through IPDMS and submit a copy to State Drug Controller and dealers. Every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.
NPPA sets Retail Prices for 19 Formulations
Manufacturers of specific formulations categorized as “new drugs” under the Drug Price Control Order (DPCO), 2013 (DPCO, 2013) are required to set the retail price as indicated in this notification. Manufacturers can add Goods and Services Tax to the retail price only if they have already paid or are liable to pay the government on the mentioned retail price. Manufacturers must issue a price list in Form–V via IPDMS to the National Pharmaceutical Pricing Authority (NPPA) and submit copies to State Drug Controllers and dealers.
NPPA Takes Measures to Ensure Price Transparency in Pharmaceutical Market
As per existing regulations, every manufacturer producing a scheduled or non-scheduled formulation for sale must prominently display the maximum retail price (MRP) on the label of the container, along with the words “Maximum Retail Price” and “inclusive of all taxes.” Additionally, manufacturers are required to issue a price list to dealers, who must prominently display it on their business premises.
NPPA sets Retail Prices for 51 Formulations
The ceiling price for a pack of scheduled formulations should be determined by the concerned manufacturer in accordance with the ceiling price specified. Manufacturers are required to issue a price list in Form-V from the date of notification, as per the Drugs Price Control Order (DPCO), 2013, to the NPPA through IPDMS. A copy of the price list should also be submitted to the State Drug Controller and dealers.
